MTVA MetaVia Inc.
Company Analysis
Latest News
🟢 MetaVia is trading 5.5% up today with no clear company-specific catalyst
MetaVia is trading 5.5% up at $1.92 after no clear company-specific catalyst emerged for September 03, 2026, with the move appearing aligned with broader risk...
🔴 MetaVia is trading 7.68% down in after-hours trading with no clear company-specific catalyst identified
MetaVia is trading 7.68% down at $1.68 after no clear company-specific catalyst was identified for September 2, 2026. - The investor-relations page lists...
🟢 MetaVia is trading 5.8% up today with no clear catalyst
MetaVia is trading 5.8% up now at $1.82, with no clear catalyst identified. - No company-specific announcement, filing, analyst action, or other clear...
🔴 MetaVia is trading 5% down in pre-market; no clear company-specific catalyst identified
MetaVia is trading at $1.63, down 5.23%, with no clear company-specific catalyst identified for September 1, 2026. - Investor relations lists August 6 as the...
🟢 MetaVia is trading 6.32% up in pre-market with no clear catalyst identified
MetaVia is trading 6.32% up at $1.76, with no clear company-specific announcement or overnight catalyst identified for August 28, 2026. - Its...
🔴 MetaVia is trading 5.25% down in pre-market with no company-specific catalyst identified
MetaVia is trading 5.25% down at $1.59 after no new company-specific announcement was identified for August 27, 2026. - Its investor-relations page lists...
🟢 MetaVia is trading 11.16% up today with no clear catalyst identified
MetaVia is trading 11.16% up at $1.70, with no clearly reported catalyst identified for August 25, 2026. - The latest major corporate update was the August 6,...
🟢 MetaVia is trading 6% up today
MetaVia is trading 5.97% higher at $1.62, extending its August 24 close of $1.53; no new company-specific announcement or clearly reported catalyst was...
🟢 MetaVia is trading 6.16% up in pre-market; reason unconfirmed
MetaVia is trading at $1.55 (+6.16%), with no clear catalyst identified. - No clear company-specific announcement or overnight catalyst was identified for...
🟢 MetaVia is trading 5.56% up in pre-market
MetaVia is trading at $1.52 (+5.56%) in pre-market, with no clear company-specific catalyst identified. - No clear company-specific catalyst was identified...
🟢 MetaVia is trading 5% up today as July CPI reduced rate-hike expectations
MetaVia is trading 5.01% up now at $1.49, moving higher alongside a broader risk-on session after July CPI showed inflation at 3.4% year over year and reduced...
MetaVia Inc. Q2 2026 Earnings Preview: What Analysts Expect on August 06, 2026
MetaVia is expected to report a Q2 2026 loss of $0.85 per share on zero revenue, while the current stock price of $1.48 remains significantly below the average...
🟢 MetaVia is trading 5.6% up today amid a broad tech and software rally
MetaVia is trading at $1.50, up 5.6% today, bouncing from recent weakness amid a broad rally in software and technology names. • The software sector is up...
🟢 MetaVia is trading 6.8% up today amid small-cap volatility
MetaVia is trading at $1.61 (+6.76%) in pre-market action, rebounding from a weak prior session despite the absence of any visible company-specific...
🔴 MetaVia is trading 11.9% down today amid technical selling and sector uncertainty
MetaVia is trading 11.9% down at $1.48 amid continued technical and sentiment-driven selling following prior financing-related volatility. - The move occurs...
🟢 MetaVia is trading 6.1% up today as it rebounds from recent sector pressure
MetaVia is trading at $1.81 (6.1% up) in pre-market, rebounding from last week’s tech-led selloff and several consecutive weak sessions. • The move appears to...
🔴 MetaVia is trading 5.6% down today amid continued selling pressure and broad tech weakness
MetaVia is trading at $1.70 (5.6% down) following a weak open and continued pressure from the prior session's decline. • No company-specific catalysts have...
🔴 MetaVia is trading 6.7% down today as obesity drug rally cools and profit-taking continues
MetaVia is trading at $1.80, down 6.7% in pre-market, extending a pullback that began after profit-taking on July 14, 2026. • The stock has experienced...
🔴 MetaVia is trading 7.5% down today as traders take profits following a surge on obesity drug trial progress
MetaVia is trading 7.5% down at $1.94 as investors lock in gains following a sharp rally driven by optimism surrounding its DA-1726 obesity drug trial...
🔴 MetaVia is trading 10.5% down
MetaVia is trading at $1.78, down 10.5% from a comparison close of $1.99 during pre-market. This is a price-action follow-up, so a separate catalyst may not be...